Zolmitriptan
Zolmitriptan (Zomig) is a migraine treatment used to relieve headache and associated symptoms. This catalogue contains one listed formulation of the active ingredient.
Key points
- Zolmitriptan is a migraine medicine that works by narrowing blood vessels in the brain.
- The 5 mg dose is sold under the originator brand Zomig, marketed by AstraZeneca, in the Neurology category.
- It may not be suitable for people with heart or blood vessel conditions; the label carries specific safety restrictions.
What Zolmitriptan is used for
Zolmitriptan belongs to a group of migraine medicines called triptans. The ingredient zolmitriptan is listed in this catalogue as Zomig, a 5 mg product marketed by AstraZeneca, and is used for the relief of Migraine attacks.